{"transactions":[{"id":795507,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2026-05-01T20:08:42.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":48800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted pursuant to the Company's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following May 1, 2026, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":48800,"derivative":{"exercise_price":2.82,"expiration_date":"2036-05-01","underlying":"Common Stock, par value $0.0001","underlying_shares":48800},"source":{"system":"sec-edgar","filing":"0001409939-26-000004","document":"form4-05012026_080538.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000140993926000004/form4-05012026_080538.xml","form_type":"4"}},{"id":814376,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2026-04-06T20:05:16.000Z","date":"2026-04-06","kind":"purchase","planned":false,"acquired":true,"shares":9200,"price":3.4076,"value":31349.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.4050 to $3.4080, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":21700,"source":{"system":"sec-edgar","filing":"0001409939-26-000002","document":"form4-04062026_040403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000140993926000002/form4-04062026_040403.xml","form_type":"4"}},{"id":959500,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2025-12-23T21:10:05.000Z","date":"2025-12-23","kind":"purchase","planned":false,"acquired":true,"shares":12500,"price":4.1,"value":51250.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001409939-25-000005","document":"form4-12232025_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000140993925000005/form4-12232025_041201.xml","form_type":"4"}},{"id":1031152,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2025-09-29T20:17:01.000Z","date":"2025-09-25","kind":"grant","planned":false,"acquired":true,"shares":48800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 25, 2025, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":48800,"derivative":{"exercise_price":3.92,"expiration_date":"2035-09-25","underlying":"Common Stock, par value $0.0001","underlying_shares":48800},"source":{"system":"sec-edgar","filing":"0001104659-25-094493","document":"tm2527377-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000110465925094493/tm2527377-5_4seq1.xml","form_type":"4"}},{"id":1031151,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2025-09-29T20:17:01.000Z","date":"2022-01-06","kind":"gift","planned":false,"acquired":false,"shares":2714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a bona fide gift of 2,714 shares of common stock made on January 6, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain Section 16 reports previously filed by the reporting person inadvertently overstated the reporting person's direct common stock ownership by 57 shares. As of the date of this filing, the reporting person does not hold any shares of common stock directly or indirectly."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-094493","document":"tm2527377-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000110465925094493/tm2527377-5_4seq1.xml","form_type":"4"}},{"id":1397834,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2024-09-30T22:34:16.000Z","date":"2024-09-26","kind":"grant","planned":false,"acquired":true,"shares":34900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 26, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":34900,"derivative":{"exercise_price":6.81,"expiration_date":"2034-09-26","underlying":"Common Stock, par value $0.0001","underlying_shares":34900},"source":{"system":"sec-edgar","filing":"0001104659-24-104439","document":"tm2425266d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000110465924104439/tm2425266d3_4.xml","form_type":"4"}},{"id":1771448,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2023-09-29T21:00:53.000Z","date":"2023-09-28","kind":"grant","planned":false,"acquired":true,"shares":26100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 28, 2023, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":26100,"derivative":{"exercise_price":2.5,"expiration_date":"2033-09-28","underlying":"Common Stock, par value $0.0001","underlying_shares":26100},"source":{"system":"sec-edgar","filing":"0001104659-23-105393","document":"tm2327241-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000110465923105393/tm2327241-4_4seq1.xml","form_type":"4"}},{"id":1833666,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2023-07-06T22:00:14.000Z","date":"2022-08-12","kind":"sale","planned":false,"acquired":false,"shares":2714,"price":15,"value":40710.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to that certain Form 5 filed on February 14, 2022, the Reporting Person gifted these 2,714 shares of common stock on December 27, 2021 to an immediate family member."}],"balance_after":2771,"source":{"system":"sec-edgar","filing":"0001104659-23-078839","document":"tm2320770-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000110465923078839/tm2320770-1_4seq1.xml","form_type":"4"}},{"id":2148633,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2022-10-01T01:21:57.000Z","date":"2022-09-29","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 29, 2022, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":23500,"derivative":{"exercise_price":12.62,"expiration_date":"2032-09-29","underlying":"Common Stock, par value $0.0001","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001104659-22-104778","document":"tm2227177-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000110465922104778/tm2227177-4_4seq1.xml","form_type":"4"}},{"id":2397662,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2022-02-14T22:01:29.000Z","date":"2021-12-27","kind":"gift","acquired":false,"shares":2714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was a bona fide gift of common stock made on December 27, 2021."},{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction was a bona fide gift of common stock made on December 27, 2021."}],"balance_after":2771,"source":{"system":"sec-edgar","filing":"0001104659-22-023082","document":"tm226690d1_5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000110465922023082/tm226690d1_5.xml","form_type":"5"}},{"id":2397661,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2022-02-14T22:01:29.000Z","date":"2021-12-27","kind":"gift","acquired":false,"shares":2714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was a bona fide gift of common stock made on December 27, 2021."},{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction was a bona fide gift of common stock made on December 27, 2021."}],"balance_after":5485,"source":{"system":"sec-edgar","filing":"0001104659-22-023082","document":"tm226690d1_5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000110465922023082/tm226690d1_5.xml","form_type":"5"}},{"id":2397660,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2022-02-14T22:01:29.000Z","date":"2021-05-03","kind":"gift","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a bona fide gift of common stock made on May 3, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was a bona fide gift of common stock made on May 3, 2021."}],"balance_after":8199,"source":{"system":"sec-edgar","filing":"0001104659-22-023082","document":"tm226690d1_5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000110465922023082/tm226690d1_5.xml","form_type":"5"}},{"id":2559793,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2021-09-25T00:45:50.000Z","date":"2021-09-23","kind":"grant","acquired":true,"shares":24100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 23, 2021, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":24100,"derivative":{"exercise_price":15.44,"expiration_date":"2031-09-23","underlying":"Common Stock, par value $0.0001","underlying_shares":24100},"source":{"system":"sec-edgar","filing":"0001104659-21-119483","document":"tm2128463-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000110465921119483/tm2128463-2_4seq1.xml","form_type":"4"}},{"id":2960497,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2020-12-03T00:05:08.000Z","date":"2020-11-30","kind":"sale","acquired":false,"shares":8425,"price":11.92,"value":100426.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":11199,"source":{"system":"sec-edgar","filing":"0000899243-20-032575","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000089924320032575/doc4.xml","form_type":"4"}},{"id":3005084,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (\"RSUs\")","published_at":"2020-10-16T23:00:21.000Z","date":"2020-09-24","kind":"exercise","acquired":false,"shares":16850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16850},"source":{"system":"sec-edgar","filing":"0000899243-20-028539","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000089924320028539/doc4.xml","form_type":"4"}},{"id":3005083,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2020-10-16T23:00:21.000Z","date":"2020-09-24","kind":"exercise","acquired":true,"shares":16850,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19624,"source":{"system":"sec-edgar","filing":"0000899243-20-028539","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000089924320028539/doc4.xml","form_type":"4"}},{"id":3021651,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2020-09-28T22:00:09.000Z","date":"2020-09-24","kind":"grant","acquired":true,"shares":25500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 24, 2020, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":25500,"derivative":{"exercise_price":12.03,"expiration_date":"2030-09-24","underlying":"Common Stock, par value $0.0001","underlying_shares":25500},"source":{"system":"sec-edgar","filing":"0000899243-20-026409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000089924320026409/doc4.xml","form_type":"4"}},{"id":3097485,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (\"RSUs\")","published_at":"2020-06-30T01:50:57.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":16850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date."}],"balance_after":16850,"derivative":{"underlying":"Common Stock","underlying_shares":16850},"source":{"system":"sec-edgar","filing":"0000899243-20-017826","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000089924320017826/doc4.xml","form_type":"4"}},{"id":3703730,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2019-01-04T22:11:50.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes vested and exercisable in two equal installments on February 28, 2019 and August 30, 2019, in each case, generally subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.6,"expiration_date":"2029-01-02","underlying":"Common Stock, par value $0.0001","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001012975-19-000035","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000101297519000035/edgar.xml","form_type":"4"}},{"id":4184759,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2017-10-18T00:12:03.000Z","date":"2017-10-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":2.5,"exercise_date":"2018-04-30","expiration_date":"2027-10-13","underlying":"Common Stock, par value $0.0001","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001012975-17-000764","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000101297517000764/edgar.xml","form_type":"4"}},{"id":4290988,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2017-06-06T20:49:26.000Z","date":"2017-06-02","kind":"purchase","acquired":true,"shares":1000,"price":4.3435,"value":4343.5,"ownership":{"direct":true},"balance_after":83224,"source":{"system":"sec-edgar","filing":"0001012975-17-000474","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000101297517000474/edgar.xml","form_type":"4"}},{"id":4542966,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-11-23T21:47:48.000Z","date":"2016-11-22","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.2,"exercise_date":"2016-11-17","expiration_date":"2026-05-31","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001144204-16-136389","document":"v453827_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000114420416136389/v453827_4.xml","form_type":"4"}},{"id":4542965,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2016-11-23T21:47:48.000Z","date":"2016-11-22","kind":"exercise","acquired":true,"shares":100000,"price":2.2,"value":220000.0,"ownership":{"direct":true},"balance_after":822244,"source":{"system":"sec-edgar","filing":"0001144204-16-136389","document":"v453827_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000114420416136389/v453827_4.xml","form_type":"4"}},{"id":4599906,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-09-19T22:00:05.000Z","date":"2016-09-16","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.47,"exercise_date":"2009-08-05","expiration_date":"2019-08-05","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-16-124460","document":"v449040_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000114420416124460/v449040_4.xml","form_type":"4"}},{"id":4599905,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-09-19T22:00:05.000Z","date":"2016-09-16","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.59,"exercise_date":"2009-03-09","expiration_date":"2018-06-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001144204-16-124460","document":"v449040_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000114420416124460/v449040_4.xml","form_type":"4"}},{"id":4599904,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-09-19T22:00:05.000Z","date":"2016-09-15","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.51,"exercise_date":"2015-06-18","expiration_date":"2024-06-17","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-16-124460","document":"v449040_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000114420416124460/v449040_4.xml","form_type":"4"}},{"id":4599903,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-09-19T22:00:05.000Z","date":"2016-09-15","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.64,"exercise_date":"2014-06-11","expiration_date":"2023-06-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-16-124460","document":"v449040_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000114420416124460/v449040_4.xml","form_type":"4"}},{"id":4599902,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-09-19T22:00:05.000Z","date":"2016-09-15","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.45,"exercise_date":"2013-06-22","expiration_date":"2022-06-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-16-124460","document":"v449040_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000114420416124460/v449040_4.xml","form_type":"4"}},{"id":4599901,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-09-19T22:00:05.000Z","date":"2016-09-15","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.6,"exercise_date":"2010-06-23","expiration_date":"2020-06-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-16-124460","document":"v449040_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000114420416124460/v449040_4.xml","form_type":"4"}},{"id":4599900,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2016-09-19T22:00:05.000Z","date":"2016-09-16","kind":"exercise","acquired":true,"shares":20000,"price":2.47,"value":49400.0,"ownership":{"direct":true},"balance_after":722244,"source":{"system":"sec-edgar","filing":"0001144204-16-124460","document":"v449040_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000114420416124460/v449040_4.xml","form_type":"4"}},{"id":4599899,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2016-09-19T22:00:05.000Z","date":"2016-09-16","kind":"exercise","acquired":true,"shares":10000,"price":2.59,"value":25900.0,"ownership":{"direct":true},"balance_after":702244,"source":{"system":"sec-edgar","filing":"0001144204-16-124460","document":"v449040_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000114420416124460/v449040_4.xml","form_type":"4"}},{"id":4599898,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2016-09-19T22:00:05.000Z","date":"2016-09-15","kind":"exercise","acquired":true,"shares":20000,"price":1.51,"value":30200.0,"ownership":{"direct":true},"balance_after":692244,"source":{"system":"sec-edgar","filing":"0001144204-16-124460","document":"v449040_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000114420416124460/v449040_4.xml","form_type":"4"}},{"id":4599897,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2016-09-19T22:00:05.000Z","date":"2016-09-15","kind":"exercise","acquired":true,"shares":20000,"price":1.64,"value":32800.0,"ownership":{"direct":true},"balance_after":672244,"source":{"system":"sec-edgar","filing":"0001144204-16-124460","document":"v449040_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000114420416124460/v449040_4.xml","form_type":"4"}},{"id":4599896,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2016-09-19T22:00:05.000Z","date":"2016-09-15","kind":"exercise","acquired":true,"shares":20000,"price":1.45,"value":29000.0,"ownership":{"direct":true},"balance_after":652244,"source":{"system":"sec-edgar","filing":"0001144204-16-124460","document":"v449040_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000114420416124460/v449040_4.xml","form_type":"4"}},{"id":4599895,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50277,"kind":"person","name":"GILL JOHN","position":1,"cik":"0001409939","reported_name":"GILL JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2016-09-19T22:00:05.000Z","date":"2016-09-15","kind":"exercise","acquired":true,"shares":20000,"price":1.6,"value":32000.0,"ownership":{"direct":true},"balance_after":632244,"source":{"system":"sec-edgar","filing":"0001144204-16-124460","document":"v449040_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409939/000114420416124460/v449040_4.xml","form_type":"4"}}]}